Абстракт

Objectives: Botulinum Toxin type A (BTXA) has been documented for its use in breast augmentation. Intradermal, fascial, and intramuscular injections of BTXA are administered directly to the breast to achieve results. Furthermore, intradermal injection of BTXA on the breast has been documented to be effective in treating saggy breasts. In this study, we determined the efficacy of BTXA injections for breast augmentation and breast lift. Introduction: 35 patients were injected with BTXA on the breast and followed up for eight weeks to determine the efficacy of BTXA injections for breast augmentation. Also, 40 patients were injected with BTXA using only the intradermal injection technique to assess the breast lifting effects of BTXA injections. Results: Improvements in breast shape and size were recorded as soon as two weeks after the injections. After eight weeks, the average enlargement from the injections was equivalent to the surgical placement of a 100-cc silicone implant. Moreover, 40 patients were injected BTXA on the breast intradermally to determine the breast lifting effects of BTXA. Visible lifting was observed immediately following the injections. Conclusion: BTXA injection into the breast is a safe and effective alternative for breast augmentation and breast lift surgeries. The technique is limited to women with mild breast sagging and women looking for moderate enhancements to their breast size. However, the injections are practical for patients and surgeons due to minimal invasiveness compared to traditional surgical procedures.